Objective: To estimate responsiveness of prescription demandwithin 9 therapeutic classes to increased cost-sharing comparedwith constant cost-sharing. Study Design: Retrospective prescription claims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results